Skip to main content
Equibles

Arax Advisory Partners

Position in XGN — Exagen Inc.

CIK 1586767 DENVER, CO
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$97,268
+$34,514 QoQ
Shares Held
20,918
0.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 57 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Arax Advisory Partners holds $42,230,385 across 31 Diagnostics & Research names. XGN ranks #23 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ILMN
Illumina, Inc.
 56,486 $9,931,933
2 TMO
Thermo Fisher Scientific Inc.
 12,159 $6,096,036
3 NTRA
Natera, Inc.
 18,839 $5,113,846
4 IQV
Iqvia Holdings Inc.
 23,532 $4,546,853
5 DHR
Danaher Corp /De/
 22,030 $4,196,274
6 MEDP
Medpace Holdings, Inc.
 6,259 $3,314,703
7 A
Agilent Technologies, Inc.
 19,198 $2,550,070
8 IDXX
Idexx Laboratories Inc /De
 1,735 $913,373

All Filings in XGN

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $97,268 20,918
2026-03-31 $62,754 20,918